Literature DB >> 10214662

Clinical practice guidelines for the use of albumin: results of a drug use evaluation in a Paris hospital. Tenon Hospital Paris.

I Debrix1, D Combeau, F Stephan, A Benomar, A Becker.   

Abstract

Clinical practice guidelines on the prescription of albumin were instituted in our hospital according to a method which combined a review of the medical literature with experts points of view. Their broadcasting was based upon a daily patient-specific decision support which was well-documented by the prescribing physician. The method for assessing the impact was a six month analysis of the discrepancies between recommendations and clinical practice. Results were a better compliance with guidelines (25.5% before and 59% after developing recommendations), a decrease 70% in grams of albumin prescribed and in use of an increase synthetic colloids, and a savings of $57,208 per year.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10214662     DOI: 10.1023/a:1008635005398

Source DB:  PubMed          Journal:  Pharm World Sci        ISSN: 0928-1231


  13 in total

1.  Albumin supplementation in the critically ill. A prospective, randomized trial.

Authors:  E F Foley; B C Borlase; W H Dzik; B R Bistrian; P N Benotti
Journal:  Arch Surg       Date:  1990-06

2.  Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusion.

Authors:  E C Rackow; C Mecher; M E Astiz; M Griffel; J L Falk; M H Weil
Journal:  Crit Care Med       Date:  1989-05       Impact factor: 7.598

3.  [How to develop clinical practice guidelines?].

Authors:  P Dosquet; J Goldberg; Y Matillon
Journal:  Bull Cancer       Date:  1995-10       Impact factor: 1.276

4.  Comparison of hetastarch to albumin for perioperative bleeding in patients undergoing abdominal aortic aneurysm surgery. A prospective, randomized study.

Authors:  M S Gold; J Russo; M Tissot; G Weinhouse; T Riles
Journal:  Ann Surg       Date:  1990-04       Impact factor: 12.969

5.  Intravenous albumin administration for prevention of spinal hypotension during cesarean section.

Authors:  M Mathru; T L Rao; R K Kartha; M Shanmugham; H K Jacobs
Journal:  Anesth Analg       Date:  1980-09       Impact factor: 5.108

6.  Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis.

Authors:  A Ginès; G Fernández-Esparrach; A Monescillo; C Vila; E Domènech; R Abecasis; P Angeli; L Ruiz-Del-Arbol; R Planas; R Solà; P Ginès; R Terg; L Inglada; P Vaqué; F Salerno; V Vargas; G Clemente; J C Quer; W Jiménez; V Arroyo; J Rodés
Journal:  Gastroenterology       Date:  1996-10       Impact factor: 22.682

7.  Colloid solutions in the critically ill. A randomised comparison of albumin and polygeline 2. Serum albumin concentration and incidences of pulmonary oedema and acute renal failure.

Authors:  M A Stockwell; A Scott; A Day; B Riley; N Soni
Journal:  Anaesthesia       Date:  1992-01       Impact factor: 6.955

8.  A paradigm for consensus. The University Hospital Consortium guidelines for the use of albumin, nonprotein colloid, and crystalloid solutions.

Authors:  L C Vermeulen; T A Ratko; B L Erstad; M E Brecher; K A Matuszewski
Journal:  Arch Intern Med       Date:  1995-02-27

9.  Efficacy of albumin supplementation in the surgical intensive care unit: a prospective, randomized study.

Authors:  R Golub; J J Sorrento; R Cantu; D M Nierman; A Moideen; H D Stein
Journal:  Crit Care Med       Date:  1994-04       Impact factor: 7.598

10.  Intravenous albumin for the prevention of severe ovarian hyperstimulation syndrome in an in vitro fertilization program: a prospective, randomized, placebo-controlled study.

Authors:  Z Shoham; A Weissman; A Barash; R Borenstein; M Schachter; V Insler
Journal:  Fertil Steril       Date:  1994-07       Impact factor: 7.329

View more
  7 in total

Review 1.  Clinical use of albumin.

Authors:  Paolo Caraceni; Manuel Tufoni; Maria Elena Bonavita
Journal:  Blood Transfus       Date:  2013-09       Impact factor: 3.443

2.  AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update.

Authors:  Paolo Caraceni; Paolo Angeli; Daniele Prati; Mauro Bernardi; Pierluigi Berti; Francesco Bennardello; Francesco Fiorin; Pierluigi Piccoli
Journal:  Blood Transfus       Date:  2020-12-18       Impact factor: 3.443

3.  How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure.

Authors:  Federica Mirici-Cappa; Paolo Caraceni; Marco Domenicali; Ernesto Gelonesi; Barbara Benazzi; Giacomo Zaccherini; Franco Trevisani; Cristina Puggioli; Mauro Bernardi
Journal:  World J Gastroenterol       Date:  2011-08-14       Impact factor: 5.742

4.  Application of Unit-Level Cost Transparency, Education, Enhanced Audit, and Feedback of Anonymized Peer Ranking to Promote Judicious Use of 25% Albumin in Critical Care Units.

Authors:  Chiedozie I Udeh; Matthew Wanek; Belinda L Udeh; J Steven Hata
Journal:  Hosp Pharm       Date:  2019-02-10

5.  Evaluation of human albumin use in a university hospital in Belgium.

Authors:  A Somers; T Bauters; H Robays; M Bogaert; F Colardyn
Journal:  Pharm World Sci       Date:  2002-06

6.  Evaluation of Albumin 25% Use in Critically Ill Patients at a Tertiary Care Medical Center.

Authors:  Heather Torbic; Seth R Bauer; Michael Militello; Sarah Welch; Chiedozie Udeh; Steven Richardson
Journal:  Hosp Pharm       Date:  2019-01-16

7.  AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis.

Authors:  Paolo Caraceni; Paolo Angeli; Daniele Prati; Mauro Bernardi; Giancarlo M Liumbruno; Francesco Bennardello; Pierluigi Piccoli; Claudio Velati
Journal:  Blood Transfus       Date:  2016-01       Impact factor: 3.443

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.